Exosome Development and Manufacturing Services Market, 2035 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–Report “Exosome Development and Manufacturing Services Market, 2022-2035” has been added to from ResearchAndMarkets.com offer.

The “Exosome Development and Manufacturing Services Market” report presents an in-depth study of the current market landscape, offering an informed opinion on the likely future potential of exosome service providers over the next decade. The study emphasizes in-depth analysis, highlighting the diverse capabilities of various industry players engaged in this field.

Exosomes are extracellular vesicles that play an important role in cell-to-cell communication and act as carriers of nucleic acids, lipids, and proteins circulating in the body. Over time, various research studies have demonstrated the potential of exosomes in disease diagnosis and drug delivery applications, due to their ability to act as biomarkers for various diseases and to carry important functional elements. Considering the various benefits, exosomes have attracted considerable interest in the biopharmaceutical industry, which will likely lead to their increased demand.

However, the development and manufacturing of exosomes is associated with several challenges, including the lack of standardized isolation and purification methods, limited drug loading capacity, inadequate clinical-grade production, and scale-up. GMP compliant industry. Therefore, outsourcing the development and manufacturing of exosomes is considered a preferable option by companies focused on the development of exosome-based diagnostics and therapeutics.

Currently, several companies offer services for the development and manufacture of exosomes. The main benefit of engaging service providers is to overcome various challenges related to exosome development, such as exosome heterogeneity, optimization of exosome isolation, purification and characterization methods, and lack of biomarkers specific.

Moreover, in order to take full advantage of the potential of exosomes, advanced exosome technologies are being developed to fully substructure their therapeutic applications. Additionally, extensive research is being conducted to develop methods for extracting exosomes with a high level of purity and sensitivity.

The growth of research in recent years is evident from the published scientific literature and clinical trial activity in this area. The market has also seen significant partnership activity, including several technology licensing agreements. Additionally, service providers are actively enhancing their capabilities and infrastructure to meet current and projected demand for these extracellular vesicles.

Driven by ongoing research activity, technological advancements, and efforts of players offering exosome development and manufacturing services, the market is poised for healthy growth over the next decade.

One of the main objectives of the report was to assess the size of the existing market, the main growth factors and the opportunities in the market for exosome development and manufacturing services in the medium to long term.

In addition to other elements, the report includes:

  • A detailed review of 6,451 peer-reviewed scientific articles related to exosome research based on several relevant parameters, such as year of publication, type of service(s) offered, fields of emerging interest. The chapter also highlights the best journals (in terms of number of articles published and impact factor).

  • A detailed analysis of global events attended by attendees based on multiple relevant parameters, such as event year, type of event platform, event location, areas of interest emerging, active organizers (in terms of number of events), active industry and non-industry participants, designation of participants, participant’s affiliated department, active speakers (in terms of number of events). The chapter also highlights the geographic mapping of upcoming events.

  • An overview of the landscape of exosome-based technologies, with analyzes of various technology providers, based on several relevant parameters, such as the year of creation, the size of the company and the location of the headquarters.

  • An insightful analysis of patents filed/granted for exosome technologies, during the period between 2016 and 2021 (until November), taking into account several relevant parameters, such as type of patent, year of publication, year of application, geographic location, Cooperative Patent Classification (CPC), emerging areas of interest, major industrial and non-industrial players (based on patent count), and individual patent assignees (in terms of IP portfolio size), patent benchmarking, patent characteristics and patent age. The chapter also includes insightful evaluation analysis.

  • A detailed analysis of completed and ongoing clinical trials of exosomes, based on various parameters, such as trial status, trial registration year, trial registration year and enrolled patient population, trial enrollment status, trial phase and number of enrolled patients, study design, type pf sponsor/collaborator, key players (based on number number of registered trials), emerging areas of interest and location of trials (based on number of registered trials and patient population enrolled).

Answers to key questions

  • Who are the main players offering services related to exosomes?

  • What are the different technological platforms available on the market for the development of exosomes?

  • What is the relative competitiveness of different exosome service providers?

  • What types of partnership models are commonly adopted by industrial and non-industrial actors?

  • What is the focus of ongoing research activities related to exosomes?

  • How has the intellectual property landscape of exosomes evolved over the years?

  • What are the main agenda items discussed at various global exosome-related events/conferences?

  • Which companies are actively involved in conducting clinical trials for exosomes?

  • How are current and future market opportunities related to exosomes, likely to be spread across key market segments?

The report contains detailed transcripts of interviews with the following people (in alphabetical order):

  • Jonathan Carson (Head of Strategic Marketing, EVerZom)

  • Navdeep Singh (Product and Technical Manager, Clara Biotech)

  • Nicolas Rousseau (Director of Compliance and Co-founder, RoosterBio)

Main topics covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. PRESENTATION

3.1. Overview of chapters

3.2. Types of extracellular vesicles

3.2.1. Apoptotic bodies: an overview

3.2.2. Microvesicles: an overview

3.2.3. Exosomes: an overview

3.3. Composition of exosomes

3.4. Biogenesis of exosomes

3.5 Development of exosomes: an overview

3.6. Manufacture of exosomes

3.7. Outsourcing services related to exosomes

3.8. Therapeutic applications of exosomes

3.8.1. Changes in the immune system

3.8.2. Exosomes as Targeted Drug Delivery Vehicles

3.8.3. Modified exosomes

3.9. Challenges associated with the development and manufacture of exosomes

3.9.1. Lack of standardized isolation and purification methods

3.9.2. Limited medicine loading capacity

3.9.3. Inadequate clinical quality production

3.10. Future prospects

4. EXOSOME SERVICE PROVIDERS: MARKET LANDSCAPE

4.1. Overview of chapters

4.2. Exosome Service Providers: Developer Landscape

4.3. Analysis by type of service(s) offered

5. COMPETITIVENESS ANALYSIS

5.1. Overview of chapters

5.2. Key assumptions and parameters

5.3. Scope and methodology

6. COMPANY PROFILES: EXOSOME SERVICE PROVIDERS

6.1. Overview of chapters

6.2. Key players based in North America

6.2.1. Creative bioarray

6.2.2 Creative biolabs

6.2.3. Creative biostructure

6.3. Main players based in Europe

6.3.1. Amsbio

6.3.2. Cambridge Biosciences

6.3.3. lonza

6.3.4. Qiagen

6.4. Key players based in Asia-Pacific

6.4.1. Exopharm

6.4.2. Sumika Chemical Analysis Service

7. PARTNERSHIPS AND COLLABORATIONS

7.1. Overview of chapters

7.2. Partnership models

7.3. Exosome service providers: list of partnerships and collaborations

8. ANALYSIS OF PUBLICATIONS

8.1. Overview of chapters

8.2. Scope and methodology

9. OVERALL ANALYSIS OF EVENTS

9.1. Overview of chapters

9.2. Scope and methodology

9.3. List of world events related to exosomes

10. EXOSOME-BASED TECHNOLOGIES: MARKET OVERVIEW

10.1. Overview of chapters

10.2. Exosome technologies: an overview

10.3. List of Exosome technology providers

10.4 Exosome Technologies: Technology-Related Services and Therapeutic Applications Information

11. PATENT ANALYSIS

11.1. Overview of chapters

11.2. Scope and methodology

11.3. Exosome Technologies: Patent Analysis

11.4. Exosome Technologies: Patent Benchmarking

11.5 Analysis of patents by age

11.6. Patent Valuation Analysis

11.7. Top patents by number of citations

12. ANALYSIS OF CLINICAL TRIALS

12.1. Overview of chapters

12.2. Scope and methodology

12.3. Analysis by trial status

12.4. Analysis by year of enrollment in the trial

12.5. Analysis by year of trial enrollment and enrolled patient population

12.6. Analysis by trial recruitment status

12.7. Analysis by trial phase and number of enrolled patients

12.8. Analysis by study plan

12.9. Analysis by Type of Sponsor / Collaborator

12.10. Key Players: Analysis by Number of Trials Registered

12.11. Word Cloud Analysis: Emerging Areas of Interest

12.12. Geographical analysis by number of recorded trails

12.13. Geographical analysis by registered patient population

13. MARKET FORECASTS

13.1. Overview of chapters

13.2. Forecasting methodology and key assumptions

13.3. Exosome Development and Manufacturing Services: Technology Licensing Model

13.4. Global market for exosome development and manufacturing services, 2022-2035

14. CONCLUSIONS

15. MANAGEMENT OVERVIEW

15.1. Overview of chapters

15.2. EVERZOM

15.3. Clara Biotech

15.4. CoqBio

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information on this report visit https://www.researchandmarkets.com/r/ihrfrl

Comments are closed.